Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines
- 29 October 1999
- Vol. 18 (7-8), 597-603
- https://doi.org/10.1016/s0264-410x(99)00316-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High level expression and secretion of Fc-X fusion proteins in mammalian cells.Protein Engineering, Design and Selection, 1998
- Carbohydrate vaccines that induce antibodies against cancer. 1. RationaleCancer Immunology, Immunotherapy, 1997
- Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunizationProceedings of the National Academy of Sciences, 1997
- Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulationsVaccine, 1997
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.Journal of Clinical Oncology, 1994
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.The Journal of Immunology, 1991
- The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers.The Journal of Immunology, 1984
- Preparation and antitumor activity of nontoxic lipid ACancer Immunology, Immunotherapy, 1982